Trade

with

Cepheid
(NASDAQ: CPHD)
AdChoices
46.56
+0.11
+0.24%
After Hours :
46.56
0.00
0.00%

Open

46.57

Previous Close

46.45

Volume (Avg)

811.20k (727.11k)

Day's Range

45.28-46.88

52Wk Range

36.94-55.89

Market Cap.

3.26B

Dividend Rate ( Yield )

-

Beta

0.84

Shares Outstanding

70.21M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 401.29M

    • Net Income

    • -17.96M

    • Market Cap.

    • 3.26B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -7.06

    • PEG (Price/Earnings Growth) Ratio

    • 15.54

    • Beta

    • 0.84

    • Forward P/E

    • 250.00

    • Price/Sales

    • 7.33

    • Price/Book Value

    • 9.23

    • Price/Cash flow

    • 2,000.00

      • EBITDA

      • 6.51M

      • Return on Capital %

      • -5.57

      • Return on Equity %

      • -9.98

      • Return on Assets %

      • -5.57

      • Book Value/Share

      • 5.05

      • Shares Outstanding

      • 70.21M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 53.40

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • -0.32

        • Cashflow Estimate

        • 0.10

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 21.30

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 18.79

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 48.53

            • 42.70

            • Pre-Tax Margin

            • -6.58

            • 11.63

            • Net Profit Margin

            • -7.06

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 50.40

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -5.20

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -5.10

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.77

              • 0.62

              • Current Ratio

              • 4.99

              • 1.23

              • Quick Ratio

              • 3.58

              • 0.76

              • Interest Coverage

              • -4.30

              • 5.98

              • Leverage Ratio

              • 2.11

              • 2.16

              • Book Value/Share

              • 5.05

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -98.04

                • 32.15

                • P/E Ratio 5-Year High

                • -124.60

                • 325.07

                • P/E Ratio 5-Year Low

                • -26.60

                • 154.73

                • Price/Sales Ratio

                • 6.90

                • 2.24

                • Price/Book Value

                • 8.68

                • 2.92

                • Price/Cash Flow Ratio

                • 2,000.00

                • 18.35

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -9.98

                    (-7.10)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -5.57

                    (-5.00)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -5.78

                    (-6.80)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • 2.16

                  • 5.07

                  • Asset Turnover

                  • 0.79

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -16.01M
                  Operating Margin
                  -3.99
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  2,000.00
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  56.44%

                  Mutual Fund Ownership

                  69.40%

                  Float

                  74.34%

                  5% / Insider Ownership

                  1.25%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Columbia Acorn Fund

                  •  

                    5,836,000

                  • 0.00

                  • 8.31

                  • Artisan Mid Cap Fund

                  •  

                    2,462,403

                  • -33.93

                  • 3.51

                  • Fidelity® Growth Company Fund

                  •  

                    2,012,555

                  • 0.00

                  • 2.87

                  • Champlain - Small Cap Equity

                  •  

                    1,613,280

                  • 38.62

                  • 2.30

                  • Goldman Sachs Growth Opportunities Fund

                  •  

                    1,607,925

                  • -0.57

                  • 2.29

                  • Oppenheimer Global Opportunities

                  •  

                    1,600,000

                  • 0.00

                  • 2.28

                  • Vanguard Small Cap Index

                  •  

                    1,219,509

                  • 0.35

                  • 1.74

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,139,452

                  • 0.15

                  • 1.62

                  • iShares Russell 2000 (AU)

                  •  

                    1,092,071

                  • -1.01

                  • 1.64

                  • First Trust NYSE Arca Biotech Fund

                  •  

                    1,074,442

                  • -43.40

                  • 1.61

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Artisan Partners Limited Partnership

                  •  

                    8,246,979

                  • -2.53%

                  • 11.76

                  • Columbia Wanger Asset Management LLC

                  •  

                    7,467,000

                  • 0.00%

                  • 10.65

                  • Riverbridge Partners LLC

                  •  

                    5,092,523

                  • +4.47%

                  • 7.26

                  • Vanguard Group, Inc.

                  •  

                    4,231,267

                  • +0.54%

                  • 6.04

                  • Fidelity Management and Research Company

                  •  

                    3,788,029

                  • -2.93%

                  • 5.40

                  • Champlain Investment Partners, LLC

                  •  

                    2,750,605

                  • +37.03%

                  • 3.92

                  • PRIMECAP Management Company

                  •  

                    2,255,200

                  • -0.67%

                  • 3.22

                  • OppenheimerFunds, Inc.

                  •  

                    2,092,490

                  • +5.55%

                  • 2.98

                  • BlackRock Fund Advisors

                  •  

                    1,849,503

                  • -0.18%

                  • 2.64

                  • Goldman Sachs Asset Management, L.P.

                  •  

                    1,802,380

                  • +0.69%

                  • 2.57

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Cepheid was incorporated in the State of California on March 4, 1996. The Company is a molecular diagnostics company that develops, manufactures and markets integrated systems for testing in the clinical market, as well as for applic...moreation in its non-clinical markets. The Company’s systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company’s product portfolio consists of tests, reagents and systems for the clinical and non-clinical markets. The Company’s two systems are the GeneXpert and SmartCycler. The GeneXpert system, offers services in the clinical market, integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for user types ranging from reference labor...moreatories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors’ offices. The SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample. Company faces competition from a number of companies that offer products to its target markets. Company has patents covering technologies of its own and has licensed technologies from others. In addition to patents, it rely on a combination of trade secrets, copyright and trademark laws, nondisclosure agreements, licenses and other contractual provisions and technical measures to maintain and develop its competitive position with respect to intellectual property. In the Clinical market, its products are regulated as medical device products by the FDA and comparable agencies in other countries. For the Non-Clinical market, all of its products are being produced under ISO 13485 and Quality System Regulations.lessless

                  Key People

                  John L. Bishop

                  CEO/Chairman of the Board/Director

                  Thomas L. Gutshall

                  Co-Founder/Director

                  Andrew D. Miller

                  CFO/Chief Accounting Officer/Executive VP

                  Peter Farrell

                  Executive VP, Divisional

                  Dr. David H. Persing,M.D.

                  Chief Medical Officer/Chief Technology Officer/Director/Executive VP

                  • Cepheid

                  • 904 Caribbean Drive

                  • Sunnyvale, CA 94089-1189

                  • USA.Map

                  • Phone: +1 408 541-4191

                  • Fax: +1 408 541-4192

                  • cepheid.com

                  Incorporated

                  1996

                  Employees

                  1,200

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: